Globus Medical Price to Free Cash Flow Ratio 2010-2024 | GMED

Globus Medical current price to free cash flow ratio as of January 22, 2025 is 41.02.

  • Globus Medical average price to free cash flow ratio for 2024 was 42.8, a 4.59% decline from 2023.
  • Globus Medical average price to free cash flow ratio for 2023 was 44.86, a 10.67% decline from 2022.
  • Globus Medical average price to free cash flow ratio for 2022 was 50.22, a 37.29% decline from 2021.

Price to free cash flow ratio can be defined as

Globus Medical Price to Free Cash Flow Ratio 2010-2024 | GMED

  • Globus Medical average price to free cash flow ratio for 2024 was 42.8, a 4.59% decline from 2023.
  • Globus Medical average price to free cash flow ratio for 2023 was 44.86, a 10.67% decline from 2022.
  • Globus Medical average price to free cash flow ratio for 2022 was 50.22, a 37.29% decline from 2021.

Price to free cash flow ratio can be defined as

Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$214.1B
Intuitive Surgical (ISRG)$211.1B
Alcon (ALC)$41.6B
Edwards Lifesciences (EW)$41.2B
IQVIA Holdings (IQV)$35.8B
IDEXX Laboratories (IDXX)$34.3B
DexCom (DXCM)$33B
Waters (WAT)$24B
STERIS (STE)$20.7B
SONOVA HOLDING (SONVY)$19.7B
Hologic (HOLX)$15.7B
Fresenius Medical Care AG KGaA (FMS)$13.5B
Sysmex ADR (SSMXY)$11.7B
Penumbra (PEN)$10.1B
Masimo (MASI)$9.2B
Glaukos (GKOS)$8.6B
Teleflex (TFX)$8.4B
Integer Holdings (ITGR)$4.7B
Inari Medical (NARI)$4.7B
PROCEPT BioRobotics (PRCT)$4B
Veracyte (VCYT)$3.1B
Nihon Kohden (NHNKY)$2.7B
LivaNova (LIVN)$2.6B
Tandem Diabetes Care (TNDM)$2.3B
Elekta AB (EKTAY)$2.2B
TransMedics (TMDX)$1.9B
Integra LifeSciences Holdings (IART)$1.9B
Alphatec Holdings (ATEC)$1.6B
Artivion (AORT)$1.3B
RxSight (RXST)$1.2B